MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0004476
Narvs Pharma Private Limited
Narvs Pharma Private Limited - chemicals in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹94.21 Lakh
▼ 26% YoY
Net profit · FY 2024
₹1.14 Lakh
Net margin 1.2%
EBITDA · FY 2024
₹2.55 Lakh
EBITDA margin 2.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
3
As per MCA filings
About Narvs Pharma Private Limited
Data last updated:
Narvs Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 27 February 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2015PTC277334. Its GSTIN is 10AAECN8914H1ZN (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Navneet Kumar and Babli Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O A – 137 Back Side Pul Pehlad Pur, New Delhi, Delhi, India – 110044.
As per the financials filed for FY 2024, the company reported a revenue of ₹94.21 Lakh, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹1.14 Lakh (net margin 1.2%) and EBITDA of ₹2.55 Lakh (EBITDA margin 2.7%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Narvs Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0004476). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74900DL2015PTC277334
Registration Number 277334
Incorporation Date 27 February 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0004476
Recognitions & Rankings of Narvs Pharma
Contact details
Narvs Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O A – 137 Back Side Pul Pehlad Pur, New Delhi, Delhi, India – 110044
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Narvs Pharma Private Limited, buy the company report.
Comprehensive company report
Narvs Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Narvs Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Narvs Pharma Private Limited, buy the company report.
Financials of Narvs Pharma Private Limited
FY 2025 filings availableNarvs Pharma Private Limited reported revenue of ₹94.21 Lakh (down 26% YoY) for FY 2024.
Revenue · FY 2024
₹94.21 Lakh ▼ 26%
Net profit · FY 2024
₹1.14 Lakh margin 1.2%
EBITDA · FY 2024
₹2.55 Lakh margin 2.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 26%
3 years · compounded
▼ 4%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 19%
3 years · compounded
▲ 69%
5 years · compounded
▲ 17%
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 26% fall in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Narvs Pharma Private Limited, buy the company report.
Board of directors of Narvs Pharma Private Limited
Narvs Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Navneet Kumar Also directs: Nskin Pharma Private Limited | Director | 25 Mar 2022 | 4 Years 7 Months | Current |
| Babli Kumari Also directs: Meta Life Science Private Limited | Director | 25 Mar 2022 | 4 Years 7 Months | Current |
| Kanchan Kumari Soni Also directs: Nskin Pharma Private Limited | Director | 25 Mar 2022 | 4 Years 7 Months | Current |
Peer comparison
Narvs Pharma Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SSVM Enterprises Private Limited | ₹94.58 Lakh (FY 2025) | 5.0% | Chennai, Tamil Nadu, India | |||
| Dev Drugs (India) Private Limited | ₹94.58 Lakh (FY 2025) | 32.0% | New Delhi, Delhi, India | |||
| Deccan Dry Ice Private Limited | ₹94.54 Lakh (FY 2024) | 64.0% | Bangalore, Karnataka, India | |||
| Abiocis Bio-Science Private Limited | ₹94.31 Lakh (FY 2023) | -82.0% | Secunderabad, Telangana, India | |||
| Narvs Pharma Private Limitedthis company | ₹94.21 Lakh (FY 2024) | ₹1.14 Lakh | 1.2% | -26.0% | New Delhi, Delhi, India | |
| Chalasani Bio-Pharma Private Limited | ₹94.17 Lakh (FY 2023) | -79.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Kansara Scientific (OPC) Private Limited | ₹94.12 Lakh (FY 2025) | 6.0% | Rewalsar, Himachal Pradesh, India | |||
| Bonatra Healthcare Private Limited | ₹94.08 Lakh (FY 2023) | 1189.0% | Bangalore, Karnataka, India | |||
| MK Aromatics Limited | ₹94.04 Lakh (FY 2025) | -20.0% | Alathur, Tamil Nadu, India | |||
| Pruthvi Fertlizers Private Limited | ₹93.95 Lakh (FY 2018) | -90.0% | Anand, Gujarat, India |
To see the full peer comparison of Narvs Pharma Private Limited, buy the company report.
Auditor
Narvs Pharma Private Limited is audited by HIMANSHUKUMAR&ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HIMANSHUKUMAR&ASSOCIATES | FY 2017 | 022693N |
Shareholding
The shareholding of Narvs Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Narvs Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Mar 2016 | 100026730 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Narvs Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Narvs Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Narvs Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECN8914H1ZN | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Narvs Pharma Private Limited, buy the company report.
Recent activity
Narvs Pharma Private Limited has 7 board changes on record since 2016: 3 appointments and 4 cessations. The latest: Priti Verma ceased to be Director on 26 Mar 2022.
AGM
Narvs Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Narvs Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Priti Verma ceased to be Director.
Ceased
Ritesh Kumar ceased to be Director.
Ceased
Shakuntla Devi ceased to be Director.
Appointed
Babli Kumari was appointed as Director.
Appointed
Kanchan Kumari Soni was appointed as Director.
Appointed
Navneet Kumar was appointed as Director.
Ceased
Vishwajeet Kumar ceased to be Director.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100026730 was registered on 08 Mar 2016.
Incorporation
27 Feb 2015
Narvs Pharma Private Limited was registered on 27 Feb 2015 with Roc Delhi I & aged 11 years 8 months as per MCA records.
Frequently asked questions
Narvs Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 27 February 2015 (11+ years old) and is registered under CIN U74900DL2015PTC277334.
Narvs Pharma has 3 current directors:
- Navneet Kumar - Director
- Babli Kumari - Director
- Kanchan Kumari Soni - Director
The latest financial statements of Narvs Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Narvs Pharma is 10AAECN8914H1ZN, registered in Bihar.
The CIN (Corporate Identification Number) of Narvs Pharma is U74900DL2015PTC277334. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Narvs Pharma was incorporated on 27 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Narvs Pharma by revenue are SSVM Enterprises Private Limited, Dev Drugs (India) Private Limited, Deccan Dry Ice Private Limited, Abiocis Bio-Science Private Limited, Chalasani Bio-Pharma Private Limited and 4 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Priti Verma ceased to be Director on 26 Mar 2022. Ritesh Kumar ceased to be Director on 26 Mar 2022. Shakuntla Devi ceased to be Director on 26 Mar 2022. Narvs Pharma has 7 board changes on record in total.
Yes, Narvs Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0004476).
The registered office of Narvs Pharma is at CO A – 137 Back Side Pul Pehlad Pur, New Delhi, Delhi, India – 110044.
Narvs Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages